The Women’s Health Initiative Estrogen-alone Trial Had Differential Disease and Medical Expenditure Consequences across Age Groups.

OBJECTIVES: The Women’s Health Initiative (WHI) randomized trial identified age differences in the benefit-risk profile of estrogen alone (ET) use. However, WHI trial impact on disease-associated medical expenditures attributable to subsequent decreased ET utilization has not been measured. Therefor...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Menopause
Auteurs principaux: Donneyong, Macarius M., Chang, Teng-Jen, Roth, Joshua A., Guilds, McKenna, Ankrah, Daniel, Najafzadeh, Mehdi, Xu, Wendy Yi, Chlebowski, Rowan T., Margolis, Karen, Manson, JoAnn E.
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7255959/
https://ncbi.nlm.nih.gov/pubmed/32132440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000001517
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires